Autologous HER2-Specific CAR T-Cell Therapy After Lymphodepletion for Advanced Sarcoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Nature Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial
Nat Cancer 2024 Apr 24;[EPub Ahead of Print], M Hegde, S Navai, C DeRenzo, SK Joseph, K Sanber, M Wu, AZ Gad, KA Janeway, M Campbell, D Mullikin, Z Nawas, C Robertson, PR Mathew, H Zhang, B Mehta, RR Bhat, A Major, A Shree, C Gerken, M Kalra, R Chakraborty, SG Thakkar, O Dakhova, VS Salsman, B Grilley, N Lapteva, A Gee, G Dotti, R Bao, AH Salem, T Wang, MK Brenner, HE Heslop, WS Wels, MJ Hicks, S Gottschalk, N AhmedFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.